Introduction
Deep brain stimulation (DBS) has become an important treatment option for carefully screened medication resistant neurological and neuropsychiatric disorders 1） 2） . As the rationale and technical approaches for performing DBS improve, the therapy has rapidly evolved.
DBS was born as a natural extension of ablative brain procedures. The introduction of stereotactic surgery facilitated the placement of small and very accurate lesions to be applied deep within the human brain. These lesions were positioned first without, and later with physiological guidance. The era of ablation, which has also been referred to as lesion therapy, has included widely popular procedures such as pallidotomy and . Virtually all regions of the brain, spinal cord, peripheral nerves, muscles or their coverings can ultimately be accessed, with the largest limitation being the development of a reasonable rationale, and a favorable risk/benefit ratio. DBS has not however, provided a pill free existence for most patients 2） , though it has facilitated profound and meaningful life improvements for over 100,000 individuals.
We don't fully understand and appreciate the underpinnings of the positive effects of DBS. In the early years of the therapy, many experts proposed that the applied electricity in some way does not have to be applied exclusively to the brain; and the mechanism for DBS is not simply stimulation of structures.
The applications and target locations for DBS devices are rapidly expanding, with many new regions of the brain, spinal cord, peripheral nerves, and muscles now possibly accessed through this technology. We will review the idea of "electrical neuro-network modulation (ENM)"; discuss the importance of the complex neural networks underpinning the effects of DBS; discuss the expansion of brain targets; discuss the use of fiber based targets; and discuss the importance of tailoring DBS therapy to the symptom, rather than the disease. We will briefly review and address "electrical neuro-network modulation (ENM)", and we will discuss the importance of a complex network in explaining mechanism of action of DBS. We will also address what is known about the potential mechanisms of action, the expansion of target and fiber sites, and the notion that tailoring the therapy to the symptom, rather than the disease, will be important for the development of a personalized medicine approach to DBS.
The electric brain and beyond
Currently, the term DBS refers to targets stimulated "deep" within the brain tissue. If the field persists in referring to the therapy as DBS, we must define what is meant by "deep"?
Definitions excluding the cortex and/or the brain coverings would mean that the term DBS could not be used to describe electricity applied to these other areas. Also, the term DBS could not be applied to direct stimulation of the brain's many superficially located subcortical fiber bundles. These fiber bundles will likely make up the next generation of rational electrical stimulation targets. The term deep is therefore imprecise.
Beyond the brain and its coverings, there are many other potential nervous system modulation targets, all of which are potentially amenable to an electrical therapy 2） 10） 11） 17） ～ 21）
. If we continue to use the term DBS to exclusively refer to very deep brain targets, then we will be forced to coin new terminology to describe stimulation for every specific central, peripheral, and autonomic nervous system region. This approach has its merits. The general term modulation can be applied to many pharmacological, behavioral, gene therapy, neurotrophic factor, or other approaches, inclusive of electrical methodologies.
Therefore, using the term modulation or neuromodulation to apply only to the application of electricity is similar to using the term deep; it is imprecise. Electrical modulation, or alternatively ENM would provide a more accurate description of the therapy and would more broadly cover its potential mechanisms of action.
Current thinking on the mechanisms of action
A great transoceanic debate occurred in the 1990's over the mechanisms underpinning the therapeutic effects of DBS.
Initially an inhibitory hypothesis was put forth by the founding . Thus, one may reasonably conclude that the mechanisms underpinning DBS are more than just "stimulation".
The idea that applying electricity can lead to rapid changes in complex motor, mood, and behavioral symptoms raises the intriguing possibility that DBS acts on a larger neural network .
The later hypothesis has led to the rapid development of efforts aimed at unlocking signature brain patterns for various motor, mood, and cognitive changes, and to looking at electrical corticography.
Tailoring electrical neuro-network modulation
The introduction of DBS has led to an expanding list of potential indications such as Parkinson's disease, tremor, dystonia, epilepsy, cluster headache, memory loss, obsessive compulsive symptoms, tics, and depression 1） 9） 20） . Unfortunately, the indications for DBS therapy are usually referred to by disease states, rather than by disease symptoms. As DBS evolves, and we better understand its potential(s), discussions with patients should shift from disease states to specific symptoms. Doctors and interdisciplinary teams charged with selecting patients should not be as concerned with the underlying neurological or neuropsychiatric disorder, as with the specific set of symptoms that are disabling, and potentially addressable for an individual patient. Tailoring the therapy to focus on specific symptoms will be an important evolution for the field of ENM (Table 1) 2） .
The future of electrical neuro-network modulation
The immediate future of ENM will include an evolution toward symptom specific tailoring cognitive and behavioral man ifestations. Doctors, nurses, and programmers will be able to monitor and to control devices remotely. Patients will be granted more access to their personal electrical settings, and they will be granted the ability to tune their own device "in a situation dependent fashion". Telemedicine will be utilized to improve satisfaction, and to alleviate access problems for those with financial and/or travel constraints.
Collectively all of these advances will lead to more efficient and more rational device programming, and to higher overall patient satisfaction. Additionally, ENM has great potential to be coupled to other therapies in the near-future (gene therapy, neurotrophic factors, stem cells, etc.). Understanding the mechanisms of this therapy has the potential to unlock and to inform more rational pharmacological, and other novel therapeutic approaches.
In summary, the term DBS is imprecise. It is not always deep, not always brain, and not always stimulation. The use of other terms such as modulation and neuromodulation are also imprecise, as these terms can be applied to pharmacological, and other therapeutic approaches. The weight of the evidence suggests that DBS therapy involves changes across a complex neural network. Therefore, currently, what is referred to as DBS therapy, can be more precisely described by the umbrella term, electrical neuro-network modulation (ENM), and as our understanding expands on the mechanisms of action of DBS we should keep idea in mind that the network concept is critical.
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